Intermittent Versus Daily Trimethoprim/Sulfamethoxazole Regimens for Pneumocystis Pneumonia Prophylaxis: A Systematic Review and Meta-analysis

被引:1
作者
Masaki, Tetsuhiro [1 ]
Ishikawa, Kazuhiro [2 ]
Fujino, Takahisa [1 ]
Koyamada, Ryosuke [1 ]
Kawai, Fujimi [3 ]
Ota, Erika [4 ]
Mori, Shinichiro [1 ]
机构
[1] St Lukes Int Hosp, Dept Haematol, Chuo Ku, Tokyo, Japan
[2] St Lukes Int Hosp, Dept Infect Dis, 9-1 Akashi cho,Chuo Ku, Tokyo, Japan
[3] St Lukes Int Univ, Dept Acad Resources, Lib, Chuo ku, Tokyo, Japan
[4] St Lukes Int Univ, Grad Sch Nursing Sci, Chuo ku, Tokyo, Japan
关键词
daily prophylaxis; intermittent prophylaxis; PCP; Pneumocystis pneumonia; trimethoprim/sulfamethoxazole; TRIMETHOPRIM-SULFAMETHOXAZOLE; CARINII-PNEUMONIA; JIROVECII PNEUMONIA; HYPERKALEMIA; PREVENTION; RECIPIENTS; EFFICACY;
D O I
10.1093/ofid/ofae499
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background In immunocompromised individuals, trimethoprim/sulfamethoxazole (TMP/SMX) for Pneumocystis pneumonia (PCP) prophylaxis has adverse events, and the optimal dosage is unclear. The objective of this study was to assess efficacy and safety of intermittent versus daily TMP/SMX for PCP prophylaxis.Methods This systematic review included randomized controlled trials (RCTs) indexed in the Cochrane Central Register of Controlled Trials, PubMed, Ichushi, or Embase databases, published from database inception to September 2023. The inclusion criteria were adults taking intermittent or daily TMP/SMX for PCP prophylaxis. Risk of bias was assessed using the Cochrane risk-of-bias tool. The primary outcomes were PCP incidence, PCP-related mortality, and adverse events requiring temporary or permanent TMP/SMX discontinuation.Results Four RCTs (N = 2808 patients) were included. PCP incidence did not differ significantly between the intermittent and daily regimen groups (risk ratio [RR], 1.17 [95% confidence interval {CI}, .89-1.53]; certainty: very low). There was no PCP-related mortality in the 3 RCTs reporting its outcome. Compared with the daily regimen group, the intermittent regimen group experienced significantly fewer adverse events requiring temporary or permanent TMP/SMX discontinuation (RR, 0.51 [95% CI, .42-.61]; certainty: low)Conclusions This systematic review and meta-analysis suggests that intermittent TMP/SMX regimens for PCP prophylaxis may be more tolerable than daily regimens and may have similar efficacy. Further RCTs are needed to apply this to current practice. Clinical Trials Registration. PROSPERO (CRD42022359102).Conclusions This systematic review and meta-analysis suggests that intermittent TMP/SMX regimens for PCP prophylaxis may be more tolerable than daily regimens and may have similar efficacy. Further RCTs are needed to apply this to current practice. Clinical Trials Registration. PROSPERO (CRD42022359102). This systematic review and meta-analysis compared intermittent and daily trimethoprim/sulfamethoxazole regimens for Pneumocystis pneumonia prophylaxis.Our study suggests that intermittent administration may reduce adverse events; however, additional randomized controlled trials are needed to apply this to current practice.
引用
收藏
页数:7
相关论文
共 50 条
[41]   Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review [J].
Sierra, Caroline M. ;
Daiya, Krishna C. .
PHARMACOTHERAPY, 2022, 42 (11) :858-867
[42]   UTILITY OF DAPSONE FOR PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN TRIMETHOPRIM SULFAMETHOXAZOLE-INTOLERANT, HIV-INFECTED INDIVIDUALS [J].
JORDE, UP ;
HOROWITZ, HW ;
WORMSER, GP .
AIDS, 1993, 7 (03) :355-359
[43]   Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis [J].
Senecal, Julien ;
Smyth, Elizabeth ;
Del Corpo, Olivier ;
Hsu, Jimmy M. ;
Amar-Zifkin, Alexandre ;
Bergeron, Amy ;
Cheng, Matthew P. ;
Butler-Laporte, Guillaume ;
McDonald, Emily G. ;
Lee, Todd C. .
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (01) :23-30
[44]   Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole [J].
Park, Jun Won ;
Curtis, Jeffrey R. ;
Kim, Min Jung ;
Lee, Hajeong ;
Song, Yeong Wook ;
Lee, Eun Bong .
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
[45]   Adjunctive Corticosteroids for Pneumocystis jirovecii Pneumonia in Non-HIV-infected Patients: A Systematic Review and Meta-analysis of Observational Studies [J].
Fujikura, Yuji ;
Manabe, Toshie ;
Kawana, Akihiko ;
Kohno, Shigeru .
ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (02) :55-61
[46]   A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? [J].
Hernandez, A. V. ;
Thota, P. ;
Pellegrino, D. ;
Pasupuleti, V. ;
Benites-Zapata, V. A. ;
Deshpande, A. ;
Penalva de Oliveira, A. C. ;
Vidal, J. E. .
HIV MEDICINE, 2017, 18 (02) :115-124
[47]   Comparison of trimethoprim-sulfamethoxazole and aerosolized pentamidine for primary prophylaxis of Pneumocystis jiroveci pneumonia in immunocompromised patients with connective tissue disease [J].
Kimura, Miho ;
Tanaka, Sumiaki ;
Ishikawa, Akira ;
Endo, Hirahito ;
Hirohata, Shunsei ;
Kondo, Hirobumi .
RHEUMATOLOGY INTERNATIONAL, 2008, 28 (07) :673-676
[48]   Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study [J].
Taniguchi, Jumpei ;
Aso, Shotaro ;
Matsui, Hiroki ;
Fushimi, Kiyohide ;
Yasunaga, Hideo .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
[49]   Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation [J].
G. V. Ramesh Prasad ;
Jill Beckley ;
Mohit Mathur ;
Madhushankar Gunasekaran ;
Michelle M. Nash ;
Lindita Rapi ;
Michael Huang ;
Jeffrey S. Zaltzman .
BMC Infectious Diseases, 19
[50]   PCR Diagnosis of Pneumocystis Pneumonia: a Bivariate Meta-Analysis [J].
Lu, Yuan ;
Ling, Guoya ;
Qiang, Chenyi ;
Ming, Qinshou ;
Wu, Cong ;
Wang, Ke ;
Ying, Zouxiao .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (12) :4361-4363